Publications by authors named "S M Gendi"
Article Synopsis
- COVID-19 significantly affects coagulation in adult patients with congenital heart disease (ACHD), making them more susceptible to thromboembolic (TE) and bleeding complications.
- In a study from May 2020 to November 2021 involving nearly 2,000 ACHD patients, 1.5% experienced severe TE or bleeding events, which were linked to higher mortality rates and more advanced health conditions.
- Key risk factors for these complications included prior anticoagulation treatment, incidents of cardiac injury, and severity of the COVID-19 infection, with logistic regression confirming their independent associations with TE and bleeding risks.
A patient was delivered at 26 weeks (about 6 months) gestation via an emergency caesarian section. A patent ductus arteriosus (PDA) and atrial septal defect (ASD) were discovered during an echocardiogram 13 days after birth. The patient had catheter-based closure of the PDA and ASD.
View Article and Find Full Text PDFObjective: This study quantifies change in best visual acuity (BVA) over the preoperative period and assesses factors associated with postoperative outcomes.
Design: Retrospective chart review conducted at a single institution.
Participants: A total of 691 patients underwent cataract surgery and had a preoperative assessment 0-30 days prior to surgery following their surgical evaluation.
Background: Currently, no guidelines exist regarding the appropriate time from diagnosis to treatment among pancreatic adenocarcinoma patients. Herein, we aim to define the median time to treatment in pancreatic adenocarcinoma, factors associated with treatment delay, and prognostic significance.
Methods: We conducted a retrospective study of pancreatic adenocarcinoma patients, stage I-IV, at a tertiary referral center (2017-2020).
Article Synopsis
- The study aimed to evaluate the COVID-19 positivity rates during presurgical screenings for ophthalmic patients and analyze surgical outcomes, along with the overall costs involved.
- Out of 3,585 patients screened, only 13 asymptomatic cases (0.36%) tested positive, and 10 of these were newly identified infections, leading to a few surgery delays averaging 17 days.
- The total cost of screening was approximately $800,000, suggesting the need for more focused future studies on targeted presurgical testing rather than blanket testing.